Suivi thérapeutique pharmacologique de la primidone et du phénobarbital

Bentué-Ferrer, Danièle; Verdier, Marie‐Clémence; Tribut, Olivier

doi:10.2515/therapie/2012036

Cited by 11 publications

(2 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[4], les hypertrophies gingivales sous phénytoïne [5] ou encore les malformations foetales sous valproate de sodium [6]. De plus, un suivi thérapeutique pharmacologique peut être réalisé à l'échelon individuel en raison d'une marge thérapeutique étroite (relation concentration-toxicité) et/ou du risque d'interactions médicamenteuses pour certaines molécules (effet inducteur enzymatique de la carbamazépine, de la phénytoïne ou du phénobarbital) [7][8][9]. Du fait de leur diffusion au niveau du système nerveux central, les antiépileptiques exposent les patients à des effets indésirables neurologiques.…”

Section: Mots Clésunclassified

Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance

et al. 2020

View full text Add to dashboard Cite

show abstract

Section: Mots Clésunclassified

Modification de la perception des sons sous antiépileptiques : une revue de la littérature et des bases de pharmacovigilance

et al. 2020

View full text Add to dashboard Cite

show abstract

“…which have been developed have not appreciably increased seizure freedom in children diagnosed with DRE[23][24][25][26][27][28][29][30][31][32][33][34].…”

mentioning

confidence: 99%

Childhood Epilepsies and When to Refer for Epilepsy Surgery Evaluation

Miller

2024

Common Childhood Diseases - Diagnosis, Prevention and Management [Working Title]

View full text Add to dashboard Cite

Many providers feel uncomfortable with the recognition of epileptic seizures, the diagnosis and classification of epilepsy syndromes, and initial treatments to offer to patients with epilepsy. Available therapies for children with epilepsy include medical management with antiseizure medications, trial of the ketogenic diet, and evaluation for epilepsy surgeries. This chapter will highlight the diagnostic criteria for epilepsy, common epilepsy syndromes according to the recent updated International League Against Epilepsy (ILAE) Classification, and when to refer to an epilepsy center for specialized treatments if not readily available such as the ketogenic diet, phase 1 presurgical evaluation, and epilepsy surgery. This chapter will also briefly highlight frequent comorbidities with epilepsy such as psychogenic nonepileptic seizures and attention deficit hyperactivity disorder and the challenges related to seizure mimics. This chapter will therefore highlight the diagnosis, workup, and management of both medically responsive epilepsy and drug resistant epilepsy (DRE) as well as its comorbidities. This chapter is a comprehensive review of the literature for the diagnosis and treatment of epilepsy and the author’s experience of practice working at Riley Hospital for Children at Indiana University Health which is a National Association of Epilepsy Centers (NAEC) Level 4 Epilepsy Center.

show abstract